Viewing Study NCT01812603


Ignite Creation Date: 2025-12-24 @ 7:37 PM
Ignite Modification Date: 2025-12-28 @ 3:14 AM
Study NCT ID: NCT01812603
Status: COMPLETED
Last Update Posted: 2022-12-20
First Post: 2013-03-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety Study of Sativex in Combination With Dose-intense Temozolomide in Patients With Recurrent Glioblastoma
Sponsor: Jazz Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module